Whalesbook
DCM Shriram has announced its audited financial results for the fiscal year ended March 31, 2026.
The company reported a consolidated Profit After Tax (PAT) of ₹855.98 crore for FY26, an increase from ₹800.00 crore in the previous fiscal year. Standalone PAT for FY26 stood at ₹837.55 crore.
The board recommended a final dividend of ₹4 per equity share. This brings the total dividend payout for FY26 to ₹11.20 per share, up from ₹10.00 per share in FY25, representing a total payout of ₹174.66 crore.
A key development from the board meeting was the approval of a ₹101 crore capital investment for its subsidiary, Hindusthan Specialty Chemicals Ltd (HSCL). This funding is earmarked to expand Formulated Resins capacity by 36,000 tonnes per annum, increasing the total capacity to 50,000 TPA.
This strategic expansion aims to strengthen DCM Shriram's position in value-added businesses within its Chemicals portfolio, particularly in advanced materials. The increased capacity is intended to meet growing demand in the specialty chemicals sector.
Additionally, the board approved the cancellation of 39,00,000 forfeited equity shares. This action is subject to shareholder approval at the company's upcoming Annual General Meeting (AGM).
Shareholders will vote on both the final dividend and the cancellation of forfeited shares at the AGM scheduled for August 18, 2026.
Investors will be closely monitoring the progress of the ₹101 crore capacity expansion project at HSCL and the future performance of DCM Shriram's chemicals business, particularly its advanced materials segment.